Deutsche Bank
BXRX

Deutsche Bank’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Deutsche Bank’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Hold
0
– -$1K – 4499
2020
Q2 		– Sell
-2
Closed -$9.6K – 4222
2020
Q1 		$7K Hold
2
– – ﹤0.01% 4106
2019
Q4 		$18K Buy
+2
New +$17.1K ﹤0.01% 4340

Other funds holding BXRX

NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Deutsche Bank's BXRX Position: Q3 2020 in Review

Deutsche Bank held its Baudax Bio, Inc. Common Stock (BXRX) position steady in Q3 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4499.

Deutsche Bank first reported a position in BXRX in Q4 2019 and has held it in 2 quarters since. The position peaked at $18K in Q4 2019. 26 funds tracked by Wall St. Rank hold BXRX as of Q3 2020.

  • Deutsche Bank held 0 shares of Baudax Bio, Inc. Common Stock worth $0 as of Q3 2020.
  • Deutsche Bank left its Baudax Bio, Inc. Common Stock share count unchanged in Q3 2020.
  • Baudax Bio, Inc. Common Stock made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2020, its #4499 holding.
  • Deutsche Bank first reported a position in Baudax Bio, Inc. Common Stock in Q4 2019 and has held it in 2 quarters since.
  • Deutsche Bank's Baudax Bio, Inc. Common Stock position peaked at $18K in Q4 2019.
  • 26 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q3 2020.

Based on Deutsche Bank's 13F filing for Q3 2020, filed 12 Nov 2020.